Jefferies Lifts Numbers on HCA (HCA), Could Be Seeing Early Stages of a Recovery

Jefferies raised estimates and its price target HCA Holdings (NYSE: HCA) from $30 to $34, while reiterating a Buy rating.

The firm comments, "We could be in the early stages of a recovery in healthcare service utilization. If this is true, HCA, long considered the bellwether of the sector, is well positioned to outperform given its depressed valuation. HCA's dynamic cash flows could be harnessed to drive upside performance. Reiterate Buy/$34PT (from $30)."

Jefferies raised Q1 EPS form $0.80 to $0.94 and FY12 from $2.64 to $2.93.

For an analyst ratings summary and ratings history on HCA Holdings click here. For more ratings news on HCA Holdings click here.

Shares of HCA Holdings closed at $27.80 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Advance Auto Parts (AAP) PT Lowered to $48 at DA Davidson Following 25% Selloff Post Q2 Results
• Deere (DE) PT Raised to $585 at JPMorgan
• DA Davidson Starts Comfort Systems USA (FIX) at Buy